Butylphthalide
4 trials in this asset. Source: ClinicalTrials.gov, as of July 21, 2026.
Trials
4
Ongoing
1
Recruiting
0
Completed
1
Sites
4
Countries
1
Endpoints
38
Composite endpoints
0
Distinct sites and countries across this asset's trials. A site running several of its trials counts once, matching the map. All 38 linked ClinicalTrials.gov endpoints are classified into the categories below. Trial and endpoint linkage does not by itself establish treatment attribution for every endpoint.
Development
Where the program stands
Trials by phase
Trials by status
Evidence coverage
What this asset has been measured on
Endpoints grouped into outcome categories, ranked by how often they are measured across this asset's trials.
Most-measured metrics
Top 20 metrics across this asset's endpoints
Normalized metric codes are available for 10 of 38 classified ClinicalTrials.gov endpoints for this asset; the ranking below covers that coded subset.
3
2
2
2
1
Trials
Trials for this asset
Every trial for this asset, with the same search, filters, and sort as the Trials tab.
4 of 4
| Asset / Disease area | Key I/E criterion | Evidence | ||||||
|---|---|---|---|---|---|---|---|---|
| EBSCPVCINDThe Efficacy of Butylphthalide Soft Capsules in Patents With VCIND | Butylphthalide Vascular cognitive impairment / dementia | MMSE ≥24 | Ph 2/3 | Unknown | 1 | Jan 2019 | 1 | |
| NCT03906123The Efficacy of DL-NBP in Patients With Mild Subcortical Ischemic Vascular Dementia | Butylphthalide Vascular cognitive impairment / dementia | MMSE 15 | Not applicable | Unknown | 1 | Dec 2019 | - | |
| NCT03804229Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia | Butylphthalide Vascular cognitive impairment / dementia | Vascular dementia | Ph 3 | Active, not recruiting | 1 | Oct 2024 | - | |
| NCT02711683DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil | Butylphthalide, Donepezil Alzheimer’s disease | Alzheimer's disease | Not applicable | Completed | 1 | Dec 2019 | - |
Showing 1-4 of 4 trials